4//SEC Filing
Peyer James 4
Accession 0001567619-22-012841
CIK 0001829802other
Filed
Jun 13, 8:00 PM ET
Accepted
Jun 14, 4:54 PM ET
Size
8.4 KB
Accession
0001567619-22-012841
Insider Transaction Report
Form 4
Peyer James
Director10% Owner
Transactions
- Award
Restricted Stock Unit Grant
2022-06-10+4,466→ 5,235,954 total(indirect: See Footnote) - Award
Stock Option (right to buy)
2022-06-10+14,550→ 14,550 total(indirect: See Footnote)Exercise: $2.05Exp: 2032-06-09→ Common Stock (14,550 underlying)
Footnotes (3)
- [F1]These shares represent restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of the common stock of the Issuer. The shares underlying the RSUs vest in full on the first anniversary of the date of grant, or June 10, 2023, subject to the Reporting Person's continuous service with the Issuer through such vesting date.
- [F2]These shares are held by Cambrian Biopharma Inc, a Delaware corporation ("Cambrian"). The Reporting Person is the Chief Executive Officer of Cambrian and in such capacity may direct the voting and disposition of the shares held by Cambrian, subject in certain instances to the approval of Cambrian's Board of Directors. Mr. Peyer disclaims beneficial ownership of such shares.
- [F3]The shares subject to the option vest and become exercisable in 12 equal monthly installments over a one year period such that the option is fully vested on the first anniversary of the date of grant, or June 10, 2023, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date; provided that the option will in any case be fully vested on the date of the Company's next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such vesting date.
Documents
Issuer
Sensei Biotherapeutics, Inc.
CIK 0001829802
Entity typeother
Related Parties
1- filerCIK 0001843594
Filing Metadata
- Form type
- 4
- Filed
- Jun 13, 8:00 PM ET
- Accepted
- Jun 14, 4:54 PM ET
- Size
- 8.4 KB